News about Global Pharma

Aculys Pharma Names Hidemasa Tanigaki as New CEO and Representative Director

With over 30 years of extensive experience in the pharmaceutical sector, Tanigaki brings a wealth of expertise to his new role.

Global Pharma | 01/04/2024 | By Abha |  1021

Leqembi sBLA for Alzheimers IV Maintenance Moves Forward with FDA

Eisai has submitted a supplemental Biologics License Application (sBLA) for monthly lecanemab-irmb intravenous (IV) maintenance dosing to the US Food and Drug Administration (FDA).

Global Pharma | 01/04/2024 | By Manvi |  710

Sensorum Health to Improve Healthcare Delivery for Older Adults with Intermountain

Sensorum Health has teamed up with Intermountain Health to improve health outcomes and primary care access to older adults living independently with multiple chronic conditions.
<br />

Global Pharma | 01/04/2024 | By Manvi |  622

Workflow Services and Exact Sciences to Provide Easy Access of Colorectal Cancer Screening

Workflow Services has signed a new agreement with Exact Sciences, a biotechnology company that develops tests designed to prevent, detect, and guide the successful treatment of cancer.

Global Pharma | 30/03/2024 | By Manvi |  653

First Use of Kyverna KYV-101 in Patients with Progressive Multiple Sclerosis Published

Kyverna Therapeutics, Inc. has announced about a recent report published in Med that describes the first use of KYV-101, a fully human anti-CD19 chimeric antigen receptor (CAR) T-cell product candidate, in two patients suffering from progressive multiple sclerosis (MS).

Global Pharma | 30/03/2024 | By Manvi |  1174

FDA Approves Medtronic's Evolut FX+ Transcatheter Aortic Valve Replacement System

With a modified diamond-shaped frame design, the Evolut FX+ offers larger coronary access windows, providing increased space for catheter maneuverability to reach coronary arteries of varying patient anatomies.

Global Pharma | 28/03/2024 | By Abha |  635

FDA Clears PATHFAST hs-cTnI-II Test for Rapid Myocardial Infarction Diagnosis at Point of Care

Prompt diagnosis is crucial in treating patients suspected of having a heart attack.

Global Pharma | 28/03/2024 | By Abha |  1537

Akebia Gains FDA Approval of Vafseo Tablets for Treatment of Anemia

Akebia Therapeutics has declared that the US Food and Drug Administration (FDA) has approved Vafseo (vadadustat) Tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults.

Global Pharma | 28/03/2024 | By Manvi |  1173

Integral Molecular Gains ISO 9001 Certification for its MPA Services

Integral Molecular has secured IS0 9001 certification for the quality systems and processes used in its Membrane Proteome Array (MPA) specificity testing services.
<br />

Global Pharma | 28/03/2024 | By Manvi |  996

Greenway Health and DrFirst to Harness Automation Tech to Boost Medication Adherence

Greenway Health has formed a strategic partnership with DrFirst to use the power of automation technology to reduce prescription abandonment and improve medication adherence.

Global Pharma | 28/03/2024 | By Manvi |  857